- Atlas
- Engineering
- Tissue Engineering
Tissue Engineering
Tissue engineering is the attempt to build living tissue—skin, cartilage, bone, blood vessels, even whole organs—by combining cells, materials, and chemical signals in the laboratory so that the body can repair or replace what disease and injury have destroyed.
8 frameworks, from 1975 to today · Biomedical Engineering · Engineering
Overview
Tissue engineering is the attempt to build living tissue—skin, cartilage, bone, blood vessels, even whole organs—by combining cells, materials, and chemical signals in the laboratory so that the body can repair or replace what disease and injury have destroyed1. Its practitioners are engineers, biologists, surgeons, and materials scientists who share one conviction: that a damaged tissue should not merely be patched with inert material but given the living components and the structural cues it needs to rebuild itself. What is at stake is the shortage of donor organs, the failure of permanent implants, and the possibility of making replacement tissue on demand rather than waiting for a donor.
Skin, the First Engineered Tissue
The field's practical origins lie in the burn ward. In the late 1970s and early 1980s, surgeons and cell biologists worked out how to grow a patient's own skin cells in culture and return them to the wound. A landmark demonstration came from Howard Green and colleagues at Harvard, who in the late 1970s showed that human epidermal cells could be expanded enormously in culture—a small biopsy yielding sheets large enough to cover a burn patient. By the early 1980s, cultured epidermal sheets were being applied clinically. The problem this solved was severe: patients with massive burns lacked enough intact skin to graft, and donor skin was scarce and rejected. Growing the patient's own cells sidestepped rejection entirely1.
The limitation was equally clear. Epidermal sheets were fragile, had no dermis beneath them, and healed with poor mechanical quality and scarring. This pushed researchers toward bilayer constructs and toward the idea that a scaffold—a temporary structural framework—was needed to give cells a three-dimensional home.
The Scaffold Paradigm
The idea that crystallized in the 1980s and 1990s was that tissue could be engineered by seeding cells onto a porous, biodegradable scaffold that mimicked the extracellular matrix—the mesh of proteins and sugars that surrounds cells in the body and gives tissue its shape. The scaffold would provide mechanical support and a template, the cells would populate it, and the material would degrade as new tissue formed1. Robert Langer and Joseph Vacanti gave this vision its most influential statement in a 1993 paper in Science, framing tissue engineering as an interdisciplinary field drawing on materials science, cell biology, and surgery. The paper became a touchstone, and the scaffold paradigm it described dominated the field for the next two decades.
The materials problem was substantial. A scaffold had to be biocompatible, degrade at a rate matched to tissue formation, and be processable into complex shapes. Early work used synthetic polyesters such as polyglycolic acid and polylactic acid, already familiar from resorbable sutures, alongside natural materials like collagen. Fabrication methods—salt leaching to create pores, fiber spinning, gas foaming—were borrowed and adapted from polymer engineering. A concrete early success was a collagen-based skin substitute combining a porous collagen matrix with cultured cells, developed commercially in the 1990s and used for chronic wounds and burns.
The paradigm's central difficulty was that a scaffold seeded with cells in a dish is not a tissue. Cells need blood. Any construct thicker than a fraction of a millimeter starves without a blood supply, because oxygen diffuses only a short distance through living tissue.
Vascularization: The Persistent Barrier
Vascularization—giving engineered tissue a blood vessel network—became and remains one of the field's defining problems1. Approaches multiplied. Some groups seeded scaffolds with endothelial cells, the cells that line blood vessels, hoping they would self-organize into capillaries. Others prefabricated channels within scaffolds, or used growth factors such as vascular endothelial growth factor (VEGF) to coax the host's own vessels to invade the implant. Each approach worked in part and failed in part: capillaries formed but often leaked or regressed, and thick constructs still died in their interiors. The problem is not solved today; it is the reason engineered tissue has succeeded most where tissue is thin or where the host's blood supply can reach it easily.
Stem Cells and the Signaling Turn
A second transformation came from stem cell biology. Embryonic stem cells, first isolated from human embryos in 1998, and induced pluripotent stem cells—adult cells reprogrammed back to an embryonic-like state, reported by Shinya Yamanaka's group in 2006—offered a source of cells that could become any tissue type23. This changed the field's ambition: instead of harvesting a patient's mature cells, one might direct a stem cell down a chosen developmental path.
The key insight was that development itself is a set of chemical instructions. Developmental biologists had mapped the signaling pathways—the molecular conversations—that tell an embryo what to build where. Tissue engineers began to borrow these instructions, adding specific growth factors and small molecules in timed sequences to steer stem cells toward cartilage, heart muscle, or nerve. The field began to think of itself less as materials science with cells attached and more as developmental signaling engineering: reproducing, in a dish, the sequence of cues that builds a tissue in the embryo.
Decellularized Matrices
A parallel strand asked whether the best scaffold might be a real organ with its cells removed. In decellularization, a donor organ or tissue is treated with detergents and enzymes to strip away its cells, leaving behind the extracellular matrix—an intact, organ-shaped framework of collagen and other proteins, complete with its native blood vessel channels. The idea gained prominence in the mid-2000s, when researchers reported repopulating decellularized hearts and livers with new cells. The appeal was that the matrix already had the architecture and the vascular plumbing that synthetic scaffolds struggled to reproduce. The obstacles were equally real: achieving complete decellularization without damaging the matrix, and getting cells to repopulate a dense organ thoroughly enough to function.
Organoids: Tissue That Builds Itself
The most striking shift of the 2000s and 2010s was the recognition that cells, given the right conditions, can build tissue themselves. In 2009, Hans Clevers's group showed that a single intestinal stem cell could be grown into a miniature, self-organizing structure—an organoid—containing the folded architecture of the gut lining. Similar methods produced miniature kidneys, brains, and other tissues. Organoids inverted the scaffold paradigm: rather than imposing structure from outside, researchers provided a permissive environment and let the cells' own developmental programs do the organizing. Organoids became both a research tool for studying disease and development and a candidate source of tissue for therapy, though they remain small and lack a blood supply.
Bioprinting
The most recent major method is bioprinting: depositing living cells and materials layer by layer, under computer control, to build three-dimensional tissue with defined architecture. Early work in the 2000s adapted inkjet and extrusion printing to biological "inks"—hydrogels carrying cells. The promise is precise placement: putting different cell types exactly where they belong, and printing channels that could become blood vessels. The field has produced printed skin, cartilage, and small tissue constructs, and printed organ models for study. The same vascularization barrier limits it: printed tissue thick enough to matter still needs a blood supply1.
Cell Therapy and the Clinical Record
Alongside the scaffold tradition ran a simpler idea: inject or infuse cells and let the body do the rest. Cell-based therapy—delivering stem cells or progenitor cells to a damaged heart, cartilage, or wound—was pursued intensively from the 2000s. The clinical record has been mixed and instructive. Some therapies reached patients, notably cultured skin and cartilage repair techniques; many early trials reported modest or inconsistent benefits, and the field learned to demand rigorous controls. This has pushed the field toward better-defined cells and combination approaches that pair cells with materials and signals.
Where the Field Stands
Today the main approaches coexist rather than compete. Scaffold-based engineering remains the workhorse, now with smarter materials that release signals and match tissue mechanics. Decellularized matrices supply native architecture1. Stem cell and developmental signaling methods supply the cells and the instructions1. Organoids and bioprinting supply self-organization and precision placement4. Vascularization remains the central unsolved problem, and the field's clinical successes—skin, cartilage, some bladder and airway tissue—are largely in thin or well-perfused tissues. The open questions are how to build thick, vascularized tissue that survives; how to make stem cell derivatives reliably and safely; and how to move constructs from the laboratory into regulated, scalable products. The field's history is a record of learning that building living tissue means respecting biology's own rules—and that the body, given the right cues, is often the best engineer.
References
- Tissue engineering (introduction, Genetic classifications of cells, Scaffolds, Overview, Assembly methods, Modern era (20th and 21st centuries), Materials, Stem cells), Wikipedia
- Stem cell (History), Wikipedia
- Induced pluripotent stem cell, Wikipedia
- 3D bioprinting, Wikipedia
The frameworks of Tissue Engineering
Each framework is a way of working the field has used: when it held, and the question it answers.
- 1975-1995
Cultured Cell Sheet Engineering
How can a patient's own skin cells be grown to cover a wound?
- 1993-Present
Scaffold-Based Tissue Engineering
How can a porous framework guide cells to rebuild tissue?
- 1995-Present
Vascularization Strategies
How can engineered tissue be given a blood supply?
- 1998-Present
Stem Cell and Developmental Signaling Engineering
How can chemical signals steer stem cells into chosen tissues?
- 2000-Present
- 2003-Present
3D bioprinting
How can cells and materials be printed into living tissue?
- 2005-Present
Decellularization
Can a real organ's matrix serve as a scaffold for new cells?
- 2009-Present
How the ideas connect
Each arrow runs from an earlier idea to the later one it shaped. The list below says what passed between them.
Vascularization Strategies influenced by Scaffold-Based Tissue Engineering
Once cells were seeded into thick porous scaffolds, oxygen diffusion limits meant constructs thicker than a fraction of a millimeter died in their interiors. This failure of the scaffold paradigm made vascularization a central research problem, pursued by seeding endothelial cells, prefabricating channels, and delivering VEGF.
Organoid influenced by Stem Cell and Developmental Signaling Engineering
Developmental signaling work established that cells carry their own programs for building tissue when given the right chemical cues. Organoid methods, notably the 2009 intestinal organoid from a single stem cell, applied this insight by providing a permissive environment and letting the cells self-organize.
Carried by Hans Clevers.
Scaffold-Based Tissue Engineering influenced by Cultured Cell Sheet Engineering
Cultured epidermal sheet work exposed the fragility and poor mechanical quality of cell-only grafts lacking a dermal layer, which pushed researchers toward bilayer constructs and three-dimensional scaffolds. The 1993 Langer and Vacanti framing of scaffold-based tissue engineering took up this problem directly.
Carried by Howard Green; Robert Langer; Joseph Vacanti.
Stem Cell and Developmental Signaling Engineering influenced by Scaffold-Based Tissue Engineering
The scaffold paradigm supplied the materials and three-dimensional culture systems into which stem cells were later placed. After human embryonic stem cells were isolated in 1998, engineers combined these cell sources with scaffold-based constructs and began adding developmental signals in timed sequences.
3D bioprinting grew out of Scaffold-Based Tissue Engineering
Bioprinting adapted the hydrogels and cell-laden materials developed in scaffold fabrication, depositing them layer by layer under computer control. The scaffold paradigm's goal of a three-dimensional cell home carried directly into printed constructs.
3D bioprinting influenced by Vascularization Strategies
Bioprinting took up the vascularization problem by printing channels that could become blood vessels, aiming at precise placement of vessel networks. The same barrier limits printed tissue, which still needs a blood supply.
Decellularization influenced by Vascularization Strategies
The unsolved vascularization problem drove interest in decellularized matrices, which retain native blood vessel channels that synthetic scaffolds struggled to reproduce. Researchers repopulating decellularized hearts and livers cited the intact vascular plumbing as the chief appeal.
Beyond the field
Where Tissue Engineering's ideas came from in other fields, and what they led to there: the strongest 12 of 16 links.
Stem Cell and Developmental Signaling Engineering influenced by Stem cell biology and reprogramming in Developmental Biology
Stem cell biology, culminating in the induced pluripotent stem cell reprogramming of 2006, supplied the cell sources and signalling concepts that developmental-signalling engineering applies to tissue construction. Directed differentiation protocols built on this developmental and reprogramming knowledge.
Carried by Shinya Yamanaka.
Cell Therapy led to Synthetic Biology and Engineered Cell Therapy in Biomedical Engineering
Engineered cell therapy is a direct outgrowth of cell therapy: the earlier practice of transplanting living cells was refined by genetic engineering of those cells (e.g. CAR-T cells) to give them new therapeutic functions. The later field is the engineered branch of the earlier one.
Carried by Carl June; Michel Sadelain.
3D bioprinting influenced by 3D printing in Materials Processing
3D bioprinting applies the layer-by-layer deposition methods of stereolithography and other 3D printing processes to living cells and hydrogels. The printing hardware and toolpath concepts passed directly from rapid prototyping into bioprinting.
Carried by Charles Hull.
3D bioprinting influenced by 3D printing in Manufacturing Engineering
Manufacturing-engineering 3D printing supplied the deposition and extrusion machinery that bioprinting adapted for cell-laden inks. The process engineering of additive manufacturing carried over into biological printing.
Decellularization grew out of Tissue engineering scaffold paradigm in Biomaterials
Decellularized matrices are a direct extension of the tissue engineering scaffold paradigm, supplying naturally derived scaffolds in place of synthetic ones. The decellularization approach refined the paradigm by using the native extracellular matrix as the scaffold.
Carried by Stephen F. Badylak.
Decellularization grew out of Tissue engineering in Biomaterials
Decellularized tissue matrices were adopted as natural scaffolds within tissue engineering, building on the field's scaffold-and-cell paradigm. The decellularization approach grew out of the tissue engineering community's search for biomimetic scaffold materials.
Carried by Stephen F. Badylak.
Cultured Cell Sheet Engineering influenced by Pure-culture industrial microbiology in Biochemical Engineering
Cell sheet engineering grew out of techniques for growing and passaging pure cultures of mammalian cells in vitro, adapted from the aseptic pure-culture tradition of industrial microbiology. The requirement for defined, contamination-free culture conditions passed directly into the design of temperature-responsive culture surfaces.
Scaffold-Based Tissue Engineering grew out of Tissue Engineering and Regenerative Medicine in Biomedical Engineering
Regenerative medicine grew out of tissue engineering by widening its aims from implantable constructs to harnessing the body's own repair and stem cells. Scaffold-based tissue engineering became one branch within the broader regenerative-medicine programme.
Scaffold-Based Tissue Engineering influenced by Biomaterial in Biomedical Engineering
The concept of the biomaterial, especially degradable polymers designed for biological interaction, supplied the scaffold materials and design criteria of scaffold-based tissue engineering. Langer and Vacanti's synthesis drew directly on this biomaterials work.
Carried by Robert Langer.
Stem Cell and Developmental Signaling Engineering influenced by Mammalian cell culture engineering in Biochemical Engineering
Mammalian cell culture engineering provided the bioreactors, media and scale-up methods needed to expand and differentiate stem cells for tissue engineering. These culture techniques passed directly into stem-cell-based construct manufacture.
Cell Therapy influenced by Adoptive cell transfer in Immunotherapy
Adoptive cell transfer, the infusion of expanded immune cells such as tumour-infiltrating lymphocytes, supplied the clinical and manufacturing template for cell therapy. Expansion, activation and reinfusion protocols passed from adoptive immunotherapy into broader cell therapy.
Carried by Steven Rosenberg.
Cell Therapy influenced by Adoptive cell transfer in Tumor Immunology
Tumour-immunology adoptive cell transfer work established ex vivo expansion and reinfusion of patient cells as a therapeutic strategy, which cell therapy adopted as its core method. The same clinical protocols carried over.
Carried by Steven Rosenberg.

Tissue Engineering is a planet in Nousfarer
Its city has a tower for each of these 8 frameworks. Land, walk in, and climb one concept at a time.
Land on Tissue EngineeringRelated fields
Fields its ideas are linked to
- Biomedical Engineering 4 links
- Biochemical Engineering 2 links
- Biomaterials 2 links
- Developmental Biology 1 link
- Biomaterials 1 link
- Hematology 1 link
- Materials Processing 1 link
- Manufacturing Engineering 1 link
- Immunotherapy 1 link
- Tumor Immunology 1 link
- Vascular Surgery 1 link
More in Biomedical Engineering
- Bioelectronics
- Biomaterials
- Biomechanics
- Biomedical Engineering
- Biomedical Signal Processing
- Engineering Physiology
- Neural Engineering
- Rehabilitation Engineering
See where Tissue Engineering sits on the Map of Human Knowledge